EMPEROR-REDUCED Trial: main results.

Open Access

EMPEROR-REDUCED Trial: main results.

Session: New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients

Topic: Treatment

Speaker: Professor M. Packer (Dallas, US)

Organised by Charité IME, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an educational grant

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Professor Milton Packer

Baylor University Medical Center, Dallas (United States of America)

59 presentations

17 followers

4 more presentations in this session

Introduction.

Speaker: Professor J. Butler (Dallas, US)

Access

Video

SGLT2 inhibitors in HFrEF, a meta-analytical approach.

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Access

Video

Panel discussion

Speaker: Professor G. Filippatos (Athens, GR) Professor J. Butler (Dallas, US) Professor M. Packer (Dallas, US) Professor S. Anker (Berlin, DE) Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Access

Video

Conclusion.

Speaker: Professor M. Packer (Dallas, US)

Access

Video

Access the full session

New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients

Speakers: Professor M. Packer, Professor J. Butler, Professor F. Zannad, Professor G. Filippatos, Professor J. Butler...

Access

Video

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources